Can Cannabidiol Cure Autism with Blockchain?

Currently, there is no cure for autism spectrum disorder, better known as ASD, but researchers are plugging away at a new method to at least suppress the symptoms. Cannabidiol, the chemical found in the Cannabis sativa plant may be the answer doctors are looking for. On top of that, advancement in blockchain technology may add a much-needed boost in funding.

CANNABIDIOL AND BLOCKCHAIN: AUTISM ADVANCEMENT

Recently, the University of California San Diego announced it plans to test whether cannabidiol can help treat the symptoms of autism. The research is largely funded by a $4.7 million gift from private donators. As a result, doctors will be a clinical trial on 30 children. All children are between the ages of 8 and 12 years old and have moderate to severe cases of autism.

CANNABIDIOL AND BLOCKCHAIN SOLVE THE AUTISM CRISIS

For years, doctors have wondered what the secret is to treating autism. It’s nearly impossible. In fact, even just diagnosing the disease is difficult. Unlike other diseases, ASD cannot be diagnosed with a blood test. Hence, doctors need to rely on old-fashioned methods like physical observation to make a proper diagnosis. Not only does this take time but it absorbs a lot of resources as well. As a result, researchers are looking at more experimental treatment methods like cannabidiol to try to break ground on this puzzling illness. Furthermore, they are looking into blockchain based funding methods to receiving financial support.

BLOCKCHAIN TECHNOLOGY TO FUND AUTISM CANNABIDIOL RESEARCH

Over the past couple of years, fast advancements in blockchain technology resulted in new methods of fundraising. Individual, crypto startups like BestRate, Nauticus and countless others began utilizing the initial coin offering (ICO) as a quick and decentralized way to raise money for their project. Hence, medical facilities are looking at similar methods to help them raise money for underfunded research opportunities like autism. It’s still unexplored territory for the medical industry but it has massive potential.

Comments

comments